Suchergebnisse - "Li, Yanying"

PubPharm (11)

1

Bortezomib-loaded mixed micelles realize a "three-in-one" effect for enhanced breast cancer treatment

enthalten in: Biomaterials science | 2023

von Liu, J. | Xu, X. | Li, Y. | +6

2

Prolonged administration of aprepitant improves cisplatin-based chemotherapy-induced nausea and vomiting

enthalten in: Future oncology (London, England) | 2022

von Li, Y. | Sun, Y. | Liu, B. | +5

3

The Neuropeptide Y1 Receptor Ligand-Modified Cell Membrane Promotes Targeted Photodynamic Therapy of Zeolitic Imidazolate Frameworks for Breast Cancer

enthalten in: The journal of physical chemistry letters | 2021

von Wang, Y. | Cao, Y. | Jiang, Z. | +9

4

Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting "substance P-hepatic stellate cells-hepatocellular carcinoma" axis

enthalten in: Biomaterials | 2021

von Li, Z. | Wang, F. | Li, Y. | +11

5

The impact of baseline brain metastases on clinical benefits and progression patterns after first-line crizotinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer

enthalten in: Medicine | 2021

von Chen, Y. | Cai, C. | Li, Y.

6

PD-L1 expression is a promising predictor of survival in patients with advanced lung adenocarcinoma undergoing pemetrexed maintenance therapy

enthalten in: Scientific reports | 2020

von Qin, Y. | Jiang, L. | Yu, M. | +11

7

Durable complete response after afatinib and crizotinib in an advanced non-small cell lung cancer patient with EGFR L861Q mutation and acquired MET amplification : a case report

enthalten in: Annals of palliative medicine | 2020

von Long, Y. | Zhang, K. | Li, Y. | +3

8

Novel NLRC4-ALK and EML4-ALK double fusion mutations in a lung adenocarcinoma patient : A case report

enthalten in: Thoracic cancer | 2020

von Wu, X. | Wang, W. | Zou, B. | +7

9

Extraction, structure and bioactivities of the polysaccharides from Pleurotus eryngii : A review

enthalten in: International journal of biological macromolecules | 2020

von Zhang, B. | Li, Y. | Zhang, F. | +3

10

A Y1 receptor ligand synergized with a P-glycoprotein inhibitor improves the therapeutic efficacy of multidrug resistant breast cancer

enthalten in: Biomaterials science | 2019

von Wang, Y. | Jiang, Z. | Yuan, B. | +6

ErratumIn: Biomater Sci. 2024 Mar 22;:. - PMID 38517298